Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

President International Development Corporation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$76M
Portfolio companies 4
Lead investments 0
Exits 2
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Medical Device
  • Biotechnology
  • Genetics
  • Enterprise Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of President International Development Corporation:
Typical Co-investors
President International Development Corporation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after President International Development Corporation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Axon Ventures California, San Diego, United States
BAIC Group Beijing, Beijing, China
Bio/Med Investor Network Atlanta, Georgia, United States
BuzzFeed New York, New York, United States
Campus Founders Fund Salt Lake City, United States, Utah
Conviction Investment Partners Newcastle upon Tyne, North East, United Kingdom
DOT Capital New York, New York, United States
DoubleRock California, Menlo Park, United States
Health Care Service Corporation Chicago, Illinois, United States
Hillingdon Ventures -
Inventures Group California, Palo Alto, United States
Jianmin Pharmaceuticals -
Jollychic China, Hangzhou, Zhejiang
Mingyuan Hongqiao Investment Management China, Fujian, Xiamen
Success Group China, Foshan, Guangdong
Tenex Greenhouse Ventures Burlingame, California, United States
Ventura Family Office Buenaventura, Colombia, Valle del Cauca

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Insilico Medicine

Artificial Intelligence
Biotechnology
Genetics
Health Care
Pharmaceutical
$255M22 Jun 2021 Hong Kong Island, Hong Kong, China

Origene Technologies

Biotechnology
Genetics
Medical Device
Pharmaceutical
$16M24 Mar 2010 Maryland, United States
News
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

– Insilico Medicine announced that it has closed a $255m Series C.
– The financing led by Warburg Pincus, and participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, and new investors including CPE, OrbiMed, Mirae Asset Capital, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China and Sage Partners.
– The financing will be used to progress Insilico Medicine’s current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent President International Development Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 76M
Peak activity year 2002
Lead investments 0
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Insilico Medicine

Artificial Intelligence
Biotechnology
Genetics
Health Care
Pharmaceutical
$255M22 Jun 2021 Hong Kong Island, Hong Kong, China

Origene Technologies

Biotechnology
Genetics
Medical Device
Pharmaceutical
$16M24 Mar 2010 Maryland, United States
Crunchbase icon

Content report

The following text will be sent to our editors: